IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
414.52
-2.76 (-0.66%)
Nov 4, 2024, 4:00 PM EST - Market closed
IDEXX Laboratories Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 866.24 | 845.04 | 679.09 | 744.85 | 581.78 | 427.72 | Upgrade
|
| Depreciation & Amortization | 125.97 | 114.91 | 111.9 | 104.6 | 96 | 88.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.73 | 1.48 | 2.35 | 5.15 | 2.5 | 0.97 | Upgrade
|
| Stock-Based Compensation | 61.26 | 59.74 | 49.77 | 37.76 | 30.95 | 39.28 | Upgrade
|
| Provision & Write-off of Bad Debts | 5.17 | 5.55 | 5.83 | 1.48 | 4.95 | 0.66 | Upgrade
|
| Other Operating Activities | -60.86 | -47.79 | -32.42 | -0.76 | -36.35 | 7.49 | Upgrade
|
| Change in Accounts Receivable | -55.4 | -53.87 | -41.4 | -33.14 | -60.72 | -22.47 | Upgrade
|
| Change in Inventory | -21.76 | -28.65 | -121.73 | -52.92 | -18.89 | -37.31 | Upgrade
|
| Change in Accounts Payable | 8.59 | -0.56 | 3.47 | 11.23 | 0.98 | 1.96 | Upgrade
|
| Change in Unearned Revenue | -0.42 | -3.03 | -11.02 | -7.55 | -13.37 | -12.36 | Upgrade
|
| Change in Other Net Operating Assets | -13.69 | 13.68 | -102.85 | -55.15 | 60.24 | -34.79 | Upgrade
|
| Operating Cash Flow | 916.83 | 906.51 | 542.98 | 755.55 | 648.06 | 459.16 | Upgrade
|
| Operating Cash Flow Growth | 10.45% | 66.95% | -28.13% | 16.59% | 41.14% | 14.77% | Upgrade
|
| Capital Expenditures | -124.22 | -133.63 | -148.84 | -119.55 | -106.96 | -154.97 | Upgrade
|
| Cash Acquisitions | -76.69 | - | -11.51 | -173.42 | -1.5 | -50.3 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -10 | - | -0.67 | -0.26 | Upgrade
|
| Investment in Securities | - | - | -25 | - | -0.25 | - | Upgrade
|
| Other Investing Activities | 3.26 | 8.38 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -197.65 | -125.25 | -195.35 | -292.97 | -109.38 | -205.53 | Upgrade
|
| Short-Term Debt Issued | - | - | 505.5 | 73.5 | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 200 | 100 | Upgrade
|
| Total Debt Issued | - | - | 505.5 | 73.5 | 200 | 100 | Upgrade
|
| Short-Term Debt Repaid | - | -329 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -75 | -75 | -50 | -289.63 | -110.28 | Upgrade
|
| Total Debt Repaid | -150 | -404 | -75 | -50 | -289.63 | -110.28 | Upgrade
|
| Net Debt Issued (Repaid) | -150 | -404 | 430.5 | 23.5 | -89.63 | -10.28 | Upgrade
|
| Issuance of Common Stock | 42.57 | 47.03 | 35.75 | 46.57 | 51.33 | 36.11 | Upgrade
|
| Repurchase of Common Stock | -638.45 | -81.9 | -830.32 | -762.34 | -203.42 | -309.71 | Upgrade
|
| Other Financing Activities | -1.26 | -3.14 | -6.87 | -5.14 | -6.7 | -2.53 | Upgrade
|
| Financing Cash Flow | -747.14 | -442 | -370.94 | -697.41 | -248.42 | -286.41 | Upgrade
|
| Foreign Exchange Rate Adjustments | 4.9 | 2.13 | -8.61 | -4.64 | 3.33 | -0.69 | Upgrade
|
| Net Cash Flow | -23.06 | 341.39 | -31.91 | -239.47 | 293.6 | -33.47 | Upgrade
|
| Free Cash Flow | 792.6 | 772.88 | 394.15 | 636 | 541.11 | 304.19 | Upgrade
|
| Free Cash Flow Growth | 16.60% | 96.09% | -38.03% | 17.54% | 77.88% | 6.98% | Upgrade
|
| Free Cash Flow Margin | 20.61% | 21.11% | 11.71% | 19.78% | 19.99% | 12.64% | Upgrade
|
| Free Cash Flow Per Share | 9.48 | 9.20 | 4.66 | 7.35 | 6.24 | 3.47 | Upgrade
|
| Cash Interest Paid | 41 | 41 | 40.3 | 30.5 | 32.4 | 29.7 | Upgrade
|
| Cash Income Tax Paid | 264.7 | 192.5 | 239.8 | 161.7 | 110.7 | 88 | Upgrade
|
| Levered Free Cash Flow | 792.04 | 693.69 | 328.16 | 534.41 | 436.95 | 295.85 | Upgrade
|
| Unlevered Free Cash Flow | 812.65 | 719.68 | 353.07 | 553.04 | 457.65 | 315.26 | Upgrade
|
| Change in Net Working Capital | -16.24 | 7.04 | 211.49 | 52.28 | -4.25 | 9.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.